Zb. You et al., CHOLECYSTOKININ-8S INCREASES DYNORPHIN-B, ASPARTATE AND GLUTAMATE RELEASE IN THE FRONTOPARIETAL CORTEX OF THE RAT VIA DIFFERENT RECEPTOR SUBTYPES, Naunyn-Schmiedeberg's archives of pharmacology, 355(5), 1997, pp. 576-581
The effect of sulphated cholecystokinin-8 (CCK-8S) on extracellular dy
norphin B, aspartate, glutamate and GABA levels in the rat fronto-pari
etal cortex was investigated with in vivo microdialysis. The peptide w
as infused through the microdialysis probe trying to mimic local CCK-8
S release. Basal levels of dynorphin B were around 20 pM, aspartate 10
0 nM, glutamate 600 nM and GABA 30 nM. CCK-8S (10 mu M) induced a appr
oximate to 3-fold increase in extracellular dynorphin B, aspartate and
glutamate levels, while GABA levels were only slightly increased. The
effect of CCK-8S was restricted to the stimulated neocortex. Systemic
pretreatment with the CCKB antagonist, L-365, 260, but not with the C
CKA antagonist, L-364, 718, significantly antagonised the effect of CC
K-8S on cortical dynorphin B and aspartate release. However, both CCKA
and CCKB antagonists inhibited the increase in cortical glutamate lev
els. Thus, the present results indicate that cortical CCK release exer
ts a stimulatory modulation on cortical dynorphin B and aspartate rele
ase via the CCKB receptor subtype, and on glutamate release via both C
CKA and CCKB receptor subtypes. Considering electrophysiological evide
nce that CCK increases neuronal firing rates in many brain regions, it
may be suggested that CCK represents a stimulatory system modulating
the function of the neocortex.